Meeder Asset Management Inc. Has $3.71 Million Position in Agilent Technologies, Inc. $A

Posted by Francis Steltz on Aug 19th, 2026

Meeder Asset Management Inc. raised its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 13,407.7% during the 2nd quarter, HoldingsChannel reports. The firm owned 27,961 shares of the medical research company’s stock after purchasing an additional 27,754 shares during the quarter. Meeder Asset Management Inc.’s holdings in Agilent Technologies were worth $3,714,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of A. Norges Bank acquired a new position in Agilent Technologies in the 4th quarter valued at $549,158,000. Bank of New York Mellon Corp lifted its position in Agilent Technologies by 87.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after acquiring an additional 2,440,360 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after purchasing an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after buying an additional 1,340,161 shares during the last quarter. Finally, Deutsche Bank AG lifted its holdings in shares of Agilent Technologies by 17.1% during the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after buying an additional 1,024,516 shares during the last quarter.

Wall Street Analyst Weigh In

A has been the topic of several research analyst reports. Royal Bank Of Canada began coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective on the stock. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. HSBC dropped their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Robert W. Baird increased their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Finally, Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Check Out Our Latest Stock Analysis on A

Agilent Technologies Trading Up 0.1%

Shares of A stock opened at $148.66 on Wednesday. The firm has a fifty day moving average of $135.97 and a 200-day moving average of $125.68. The stock has a market cap of $41.98 billion, a price-to-earnings ratio of 29.85, a P/E/G ratio of 2.63 and a beta of 1.25. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.27. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A – Get Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the business earned $1.31 EPS. The firm’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

About Agilent Technologies

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.